<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00583505</url>
  </required_header>
  <id_info>
    <org_study_id>AGA-008 E/C</org_study_id>
    <secondary_id>G020202</secondary_id>
    <nct_id>NCT00583505</nct_id>
  </id_info>
  <brief_title>Emergency/Compassionate Use - Membranous VSD Occluder</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Medical Devices</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Medical Devices</source>
  <brief_summary>
    <textblock>
      Emergency/Compassionate use of the AMPLATZER Membranous VSD Occluder
    </textblock>
  </brief_summary>
  <overall_status>No longer available</overall_status>
  <study_type>Expanded Access</study_type>
  <condition>Membranous</condition>
  <condition>Ventricular</condition>
  <condition>Septal</condition>
  <condition>Defects</condition>
  <condition>VSD</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Device closure with the AMPLATZER Membranous VSD Occluder</intervention_name>
    <description>Device closure with the AMPLATZER Membranous VSD Occluder</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Emergency/compassionate use for patients not meeting the inclusion critera for the
             AMPLATZER Membranous VSD clinical trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>December 20, 2007</study_first_submitted>
  <study_first_submitted_qc>December 28, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 31, 2007</study_first_posted>
  <last_update_submitted>February 1, 2019</last_update_submitted>
  <last_update_submitted_qc>February 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>membranous</keyword>
  <keyword>ventricular</keyword>
  <keyword>septal</keyword>
  <keyword>defects</keyword>
  <keyword>VSD</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

